To wait, or too late? modeling the effects of delayed Ofatumumab treatment in relapsing-remitting Multiple Sclerosis

CONCLUSIONS: The DES model provided a means by which the magnitude of benefit associated with earlier ofatumumab initiation could be quantified; fewer relapses and a prolonged time to wheelchair were predicted.PMID:36546701 | DOI:10.1080/13696998.2022.2161746
Source: Journal of Medical Economics - Category: Health Management Authors: Source Type: research